Acceder

Publicaciones - CARDIOLOGIA CLINICA Y EXPERIMENTAL

Cargando...
Jover E, Marín F, Roldán V, Montoro-García S, Valdés M, Lip GY. Atherosclerosis and thromboembolic risk in atrial fibrillation: focus on peripheral vascular disease. Ann Med. 2013 May;45(3):274-90. doi: 10.3109/07853890.2012.732702. Review. PubMed PMID: 23216106.
AÑO: 2013; IF: 4.733
23216106
Capranzano P, Ferreiro JL, Ueno M, Capodanno D, Dharmashankar K, Darlington A, Desai B, Tello-Montoliu A, Rollini F, Angiolillo DJ. Pharmacodynamic effects of adjunctive cilostazol therapy in patients with coronary artery disease on dual antiplatelet therapy: impact of high on-treatment platelet reactivity and diabetes mellitus status. Catheter Cardiovasc Interv. 2013 Jan 1;81(1):42-9. doi: 10.1002/ccd.24416. PubMed PMID: 22431415.
AÑO: 2013; IF: 2.396
22431415
Ruiz-Nodar JM, Marín F, Lip GY. Antithrombotic management and type of stent in atrial fibrillation patients undergoing percutaneous coronary intervention. Rev Esp Cardiol (Engl Ed). 2013 Jan;66(1):12-6. doi: 10.1016/j.recesp.2012.07.018. English, Spanish. PubMed PMID: 23098580.
AÑO: 2013; IF: 3.342
23098580
Marín F, Huber K, Lip GY. Antithrombotic therapy in atrial fibrillation and stent implantation: treatment or threats by the use of triple or dual antithrombotic therapy. Thromb Haemost. 2013 Oct;110(4):623-5. doi: 10.1160/TH13-08-0677. PubMed PMID: 24048584.
AÑO: 2013; IF: 5.76
24048584
Tello-Montoliu A, Ferreiro JL, Kodali MK, Ueno M, Tomasello SD, Rollini F, Capodanno D, Darlington A, Patel R, Desai B, Guzman LA, Bass TA, Angiolillo DJ. Impact of renal function on clopidogrel-induced antiplatelet effects in coronary artery disease patients without diabetes mellitus. J Thromb Thrombolysis. 2013 Jul;36(1):14-7. doi: 10.1007/s11239-012-0828-1. PubMed PMID: 23143668.
AÑO: 2013; IF: 2.039
23143668
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

CARDIOLOGIA CLINICA Y EXPERIMENTAL